Overview

Therapy of the Overactive Bladder Syndrome

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate in patients with overactive bladder syndrome (OABS) whether a combination treatment of solifenacin with pelvic floor muscle training and whole body vibration training achieves a better treatment outcome than a treatment with solifenacin alone.
Phase:
Phase 4
Details
Lead Sponsor:
Cantonal Hospital, Frauenfeld
Collaborator:
Astellas Pharma Inc
Treatments:
Solifenacin Succinate